ID

38045

Beschrijving

Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01560663

Link

https://clinicaltrials.gov/show/NCT01560663

Trefwoorden

Versies (1)
  1. 11-09-19 11-09-19 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

11 september 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Breast Cancer NCT01560663

Engels

Eligibility Breast Cancer NCT01560663

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
informed consent form signed by the patient to accept study enrollment.
Beschrijving

Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
female with pathologically confirmed diagnosis of primary invasive operable breast cancer, stage iia-iiic (6th edition of the ajcc cancer staging manual), with tumors ≥
Beschrijving

Gender | Invasive carcinoma of breast Operable TNM Breast tumor staging

Datatype

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C0853879
UMLS CUI [2,2]
C0205188
UMLS CUI [2,3]
C0474926
2cm.
Beschrijving

Tumor size

Datatype

boolean

Alias
UMLS CUI [1]
C0475440
triple negative phenotype patients (re and pr of less than 1% of stained cells by ihq, ihc for her2 of 0-1+ or ish negative if 2/3+), according to local laboratory.
Beschrijving

Triple Negative Breast Neoplasm | Estrogen Receptor Measurement Immunohistochemistry | Progesterone Receptor Measurement Immunohistochemistry | HER2 Immunohistochemistry | HER2 ISH Negative

Datatype

boolean

Alias
UMLS CUI [1]
C3539878
UMLS CUI [2,1]
C3811131
UMLS CUI [2,2]
C0021044
UMLS CUI [3,1]
C3889640
UMLS CUI [3,2]
C0021044
UMLS CUI [4,1]
C0069515
UMLS CUI [4,2]
C0021044
UMLS CUI [5,1]
C0069515
UMLS CUI [5,2]
C3853647
UMLS CUI [5,3]
C1513916
age 18-75 years.
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
adequate performance status (ecog <2).
Beschrijving

ECOG performance status

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
adequate renal and liver function and bone marrow reserve.
Beschrijving

Renal function | Liver function | Bone Marrow Mature Neutrophils Present

Datatype

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0232741
UMLS CUI [3,1]
C0005953
UMLS CUI [3,2]
C1708947
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
clinical or radiologic evidence of metastatic disease.
Beschrijving

Neoplasm Metastasis

Datatype

boolean

Alias
UMLS CUI [1]
C0027627
prior or concurrent anti-cancer therapy for current disease (hormone therapy, chemotherapy, radiotherapy, immunotherapy).
Beschrijving

Cancer treatment Disease Current | Hormone Therapy | Chemotherapy | Therapeutic radiology procedure | Immunotherapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0012634
UMLS CUI [1,3]
C0521116
UMLS CUI [2]
C0279025
UMLS CUI [3]
C0392920
UMLS CUI [4]
C1522449
UMLS CUI [5]
C0021083
prior therapy with taxanes, anthracyclines or carboplatin for any malignancy.
Beschrijving

Cancer treatment Previous | taxane | Anthracyclines | Carboplatin

Datatype

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0205156
UMLS CUI [2]
C0215136
UMLS CUI [3]
C0282564
UMLS CUI [4]
C0079083
contraindication for study drugs (docetaxel or carboplatin).
Beschrijving

Medical contraindication Investigational New Drugs | Medical contraindication Docetaxel | Medical contraindication Carboplatin

Datatype

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0246415
UMLS CUI [3,1]
C1301624
UMLS CUI [3,2]
C0079083
serious concomitant systemic disorder that in the opinion of the investigator would compromise the patient's ability to complete the study, or have any other disease that could be worsened by chemotherapy or other potential support therapies.
Beschrijving

Comorbidity Systemic Serious | Comorbidity compromises Completion of clinical trial | Disease Worsening Due to Chemotherapy | Disease Worsening Due to Adjuvant therapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205373
UMLS CUI [1,3]
C0205404
UMLS CUI [2,1]
C0009488
UMLS CUI [2,2]
C2945640
UMLS CUI [2,3]
C2732579
UMLS CUI [3,1]
C0012634
UMLS CUI [3,2]
C0332271
UMLS CUI [3,3]
C0678226
UMLS CUI [3,4]
C0392920
UMLS CUI [4,1]
C0012634
UMLS CUI [4,2]
C0332271
UMLS CUI [4,3]
C0678226
UMLS CUI [4,4]
C0677850
Terug naar het begin van de pagina

Similar models

Eligibility Breast Cancer NCT01560663

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
informed consent form signed by the patient to accept study enrollment.
boolean
C0021430 (UMLS CUI [1])
Gender | Invasive carcinoma of breast Operable TNM Breast tumor staging
Item
female with pathologically confirmed diagnosis of primary invasive operable breast cancer, stage iia-iiic (6th edition of the ajcc cancer staging manual), with tumors ≥
boolean
C0079399 (UMLS CUI [1])
C0853879 (UMLS CUI [2,1])
C0205188 (UMLS CUI [2,2])
C0474926 (UMLS CUI [2,3])
Tumor size
Item
2cm.
boolean
C0475440 (UMLS CUI [1])
Triple Negative Breast Neoplasm | Estrogen Receptor Measurement Immunohistochemistry | Progesterone Receptor Measurement Immunohistochemistry | HER2 Immunohistochemistry | HER2 ISH Negative
Item
triple negative phenotype patients (re and pr of less than 1% of stained cells by ihq, ihc for her2 of 0-1+ or ish negative if 2/3+), according to local laboratory.
boolean
C3539878 (UMLS CUI [1])
C3811131 (UMLS CUI [2,1])
C0021044 (UMLS CUI [2,2])
C3889640 (UMLS CUI [3,1])
C0021044 (UMLS CUI [3,2])
C0069515 (UMLS CUI [4,1])
C0021044 (UMLS CUI [4,2])
C0069515 (UMLS CUI [5,1])
C3853647 (UMLS CUI [5,2])
C1513916 (UMLS CUI [5,3])
Age
Item
age 18-75 years.
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
adequate performance status (ecog <2).
boolean
C1520224 (UMLS CUI [1])
Renal function | Liver function | Bone Marrow Mature Neutrophils Present
Item
adequate renal and liver function and bone marrow reserve.
boolean
C0232804 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0005953 (UMLS CUI [3,1])
C1708947 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Neoplasm Metastasis
Item
clinical or radiologic evidence of metastatic disease.
boolean
C0027627 (UMLS CUI [1])
Cancer treatment Disease Current | Hormone Therapy | Chemotherapy | Therapeutic radiology procedure | Immunotherapy
Item
prior or concurrent anti-cancer therapy for current disease (hormone therapy, chemotherapy, radiotherapy, immunotherapy).
boolean
C0920425 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
C0521116 (UMLS CUI [1,3])
C0279025 (UMLS CUI [2])
C0392920 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
C0021083 (UMLS CUI [5])
Cancer treatment Previous | taxane | Anthracyclines | Carboplatin
Item
prior therapy with taxanes, anthracyclines or carboplatin for any malignancy.
boolean
C0920425 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C0215136 (UMLS CUI [2])
C0282564 (UMLS CUI [3])
C0079083 (UMLS CUI [4])
Medical contraindication Investigational New Drugs | Medical contraindication Docetaxel | Medical contraindication Carboplatin
Item
contraindication for study drugs (docetaxel or carboplatin).
boolean
C1301624 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0246415 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0079083 (UMLS CUI [3,2])
Comorbidity Systemic Serious | Comorbidity compromises Completion of clinical trial | Disease Worsening Due to Chemotherapy | Disease Worsening Due to Adjuvant therapy
Item
serious concomitant systemic disorder that in the opinion of the investigator would compromise the patient's ability to complete the study, or have any other disease that could be worsened by chemotherapy or other potential support therapies.
boolean
C0009488 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,3])
C0009488 (UMLS CUI [2,1])
C2945640 (UMLS CUI [2,2])
C2732579 (UMLS CUI [2,3])
C0012634 (UMLS CUI [3,1])
C0332271 (UMLS CUI [3,2])
C0678226 (UMLS CUI [3,3])
C0392920 (UMLS CUI [3,4])
C0012634 (UMLS CUI [4,1])
C0332271 (UMLS CUI [4,2])
C0678226 (UMLS CUI [4,3])
C0677850 (UMLS CUI [4,4])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial